Connor, Clark & Lunn Investment Management Ltd. Harvard Bioscience Inc Transaction History

Connor, Clark & Lunn Investment Management Ltd.

  • $18.8 Billion
  • Q3 2024

A detailed history of Connor, Clark & Lunn Investment Management Ltd. transactions in Harvard Bioscience Inc stock. As of the latest transaction made, Connor, Clark & Lunn Investment Management Ltd. holds 180,006 shares of HBIO stock, worth $385,212. This represents 0.0% of its overall portfolio holdings.

Number of Shares
180,006
Previous 150,399 19.69%
Holding current value
$385,212
Previous $428,000 13.08%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024
BUY
$2.64 - $3.54 $78,162 - $104,808
29,607 Added 19.69%
180,006 $484,000
Q2 2024

Aug 09, 2024
BUY
$2.77 - $4.63 $17,572 - $29,372
6,344 Added 4.4%
150,399 $428,000
Q1 2024

May 09, 2024
BUY
$4.02 - $5.39 $10,315 - $13,830
2,566 Added 1.81%
144,055 $610,000
Q4 2023

Feb 09, 2024
SELL
$4.0 - $5.49 $81,320 - $111,611
-20,330 Reduced 12.56%
141,489 $756,000
Q3 2023

Nov 13, 2023
BUY
$4.0 - $5.82 $252,696 - $367,672
63,174 Added 64.04%
161,819 $695,000
Q2 2023

Aug 10, 2023
BUY
$4.19 - $6.16 $413,322 - $607,653
98,645 New
98,645 $541,000
Q1 2022

May 12, 2022
SELL
$5.16 - $7.14 $279,940 - $387,359
-54,252 Closed
0 $0
Q4 2021

Feb 10, 2022
SELL
$6.37 - $8.18 $95,932 - $123,190
-15,060 Reduced 21.73%
54,252 $382,000
Q3 2021

Nov 12, 2021
BUY
$6.98 - $8.47 $54,088 - $65,634
7,749 Added 12.59%
69,312 $484,000
Q2 2021

Aug 12, 2021
SELL
$5.44 - $8.4 $6,185 - $9,550
-1,137 Reduced 1.81%
61,563 $513,000
Q1 2021

May 13, 2021
SELL
$3.91 - $6.99 $67,834 - $121,269
-17,349 Reduced 21.67%
62,700 $342,000
Q4 2020

Feb 16, 2021
SELL
$3.0 - $4.5 $54,522 - $81,783
-18,174 Reduced 18.5%
80,049 $343,000
Q3 2020

Nov 12, 2020
BUY
$2.75 - $4.2 $135,913 - $207,576
49,423 Added 101.28%
98,223 $296,000
Q2 2020

Aug 13, 2020
BUY
$2.12 - $3.14 $6,413 - $9,498
3,025 Added 6.61%
48,800 $151,000
Q1 2020

May 13, 2020
BUY
$1.42 - $3.29 $6,496 - $15,051
4,575 Added 11.1%
45,775 $0
Q4 2019

Feb 12, 2020
SELL
$2.45 - $3.25 $1,225 - $1,625
-500 Reduced 1.2%
41,200 $126,000
Q3 2019

Nov 13, 2019
BUY
$1.59 - $3.47 $66,303 - $144,699
41,700 New
41,700 $128,000

Others Institutions Holding HBIO

# of Institutions
97
Shares Held
30.6M
Call Options Held
700
Put Options Held
2.1K
View Full List

About HARVARD BIOSCIENCE INC

HBIO Quotes by TradingView
  • Ticker HBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 41,636,500
  • Market Cap $89.1M
  • Description
  • Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...
More about HBIO
Track This Portfolio

Track Connor, Clark & Lunn Investment Management Ltd. Portfolio

Follow Connor, Clark & Lunn Investment Management Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Connor, Clark & Lunn Investment Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Connor, Clark & Lunn Investment Management Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email